Your browser doesn't support javascript.
loading
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.
Mamounas, E P; Untch, M; Mano, M S; Huang, C-S; Geyer, C E; von Minckwitz, G; Wolmark, N; Pivot, X; Kuemmel, S; DiGiovanna, M P; Kaufman, B; Kunz, G; Conlin, A K; Alcedo, J C; Kuehn, T; Wapnir, I; Fontana, A; Hackmann, J; Polikoff, J; Saghatchian, M; Brufsky, A; Yang, Y; Zimovjanova, M; Boulet, T; Liu, H; Tesarowski, D; Lam, L H; Song, C; Smitt, M; Loibl, S.
Afiliação
  • Mamounas EP; NSABP Foundation and; Department of Surgery, Orlando Health UF Health Cancer Center, Orlando, USA. Electronic address: terry.mamounas@orlandohealth.com.
  • Untch M; AGO-B and Department of Gynecologic Oncology, HELIOS Klinikum Berlin Buch, Berlin, Germany.
  • Mano MS; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.
  • Huang CS; Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Geyer CE; NSABP Foundation and; NSABP Foundation and Department of Internal Medicine, Division of Hematology and Medical Oncology, Houston Methodist Cancer Center, Houston, USA.
  • von Minckwitz G; GBG, Neu-Isenburg, Germany.
  • Wolmark N; NSABP Foundation and; NSABP Foundation and Department of Surgery, The University of Pittsburgh, Pittsburgh, USA.
  • Pivot X; ICANS, Strasbourg, France.
  • Kuemmel S; Breast Unit Kliniken Essen-Mitte, Essen, Germany; Klinik für Gynäkologie mit Brustzentrum Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • DiGiovanna MP; Yale University School of Medicine, Yale Cancer Center and Smilow Cancer Hospital, New Haven, USA.
  • Kaufman B; Oncology Division, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Kunz G; GBG, Neu-Isenburg, Germany; St. Johannes Hospital Dortmund, Dortmund, Germany.
  • Conlin AK; NSABP Foundation and; NSABP Foundation and Department of Medical Oncology, Providence Cancer Institute, Portland, USA.
  • Alcedo JC; Department of Clinical Oncology, Centro Hemato Oncologico, Panama City, Panama.
  • Kuehn T; AGO-B and Klinikum Esslingen, Esslingen, Germany.
  • Wapnir I; NSABP Foundation and; NSABP Foundation and Stanford University School of Medicine, Stanford, USA.
  • Fontana A; Division of Medical Oncology, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Hackmann J; GBG, Neu-Isenburg, Germany; Marien-Hospital Witten, SEG, Witten, Germany.
  • Polikoff J; NSABP Foundation and; NSABP Foundation and Department of Hematology/Oncology, Kaiser Permanente, San Diego, USA.
  • Saghatchian M; Breast Cancer Department, Institut Gustave Roussy, Villejuif, France.
  • Brufsky A; NSABP Foundation and; NSABP Foundation and Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, USA.
  • Yang Y; Division of Hematology-Oncolog, Taichung Veterans General Hospital and School of Medicine, China Medical University, Taichung City, Taiwan.
  • Zimovjanova M; Department of Oncology, Charles University and General University Hospital, Prague, Czech Republic.
  • Boulet T; Department of Biostatistics, F. Hoffmann-La Roche, Basel, Switzerland.
  • Liu H; Product Development Safety, Genentech, Inc., South San Francisco, USA.
  • Tesarowski D; Product Development Oncology, Genentech, Inc., South San Francisco, USA.
  • Lam LH; Product Development Oncology, Genentech, Inc., South San Francisco, USA.
  • Song C; Product Development Oncology, Genentech, Inc., South San Francisco, USA.
  • Smitt M; Product Development Oncology, Genentech, Inc., South San Francisco, USA; Seattle Genetics, South San Francisco, USA.
  • Loibl S; GBG, Neu-Isenburg, Germany; Center for Haematology and Oncology Bethanien, Frankfurt, Germany.
Ann Oncol ; 32(8): 1005-1014, 2021 08.
Article em En | MEDLINE | ID: mdl-33932503
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article